Trial Profile
A Phase I Study of Suberoylanilide Hydroxamic Acid (SAHA) in Combination With Flavopiridol in Advanced Solid Tumors.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Vorinostat (Primary) ; Alvocidib
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 13 Feb 2012 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov.